Last reviewed · How we verify

NCT03200366

Comparing Interventions to Increase Colorectal Cancer Screening

Completed NA Results posted Last updated 13 September 2021
What this trial tests

NA trial testing Tailored DVD in Colorectal Cancer in 371 participants. Completed in 21 October 2020.

Timeline
26 July 2017
Primary endpoint
21 October 2020
21 October 2020

Quick facts

Lead sponsorIndiana University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposescreening
Enrollment371
Start date26 July 2017
Primary completion21 October 2020
Estimated completion21 October 2020
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Indiana University

Who can join

Adults 45 to 75, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Participants Completing CRC Screening Per Electronic Medical Record Documentation Primary · 12 months post-baseline interview

Number of participants completing CRC screening by any test (defined as colonoscopy or FIT) is measured by electronic medical record review. Dates that participants had a colonoscopy and dates of FIT analysis are extracted from the electronic medical record.

GroupValue95% CI
Tailored DVD37
Tailored DVD + Patient Navigation59
Usual Care27
Participants Completing Colonoscopy Per Electronic Medical Record Documentation Secondary · 12 months post-baseline interview

Number of participants completing a colonoscopy is measured by electronic medical record review (EMR). Dates that participants completed a colonoscopy are extracted from the EMR.

GroupValue95% CI
Tailored DVD24
Tailored DVD + Patient Navigation46
Usual Care20
Bowel Preparation Quality Rating Using Boston Bowel Preparation Scale Secondary · 12 months post-baseline interview

Participants quality of bowel preparation is measured by the endoscopist during their colonoscopy procedure using the Boston Bowel Preparation Scale (BBPS). BBPS scores the total quality on a 10 point scale from 0-9. Higher scores indicate better quality of bowel preparation.

GroupValue95% CI
Tailored DVD7.13± 1.90
Tailored DVD + Patient Navigation6.59± 2.40
Usual Care7.05± 2.44
Participants With Adequate Quality of Bowel Preparation Per Modified Aronchick Rating Scale Secondary · 12 months post-baseline interview

Participants quality of bowel preparation is measured by the endoscopist during their colonoscopy using a modification of the Aronchick rating scale. The Aronchick scale rates quality as 1=excellent, 2=good, 3=fair, or 4=poor. Some endoscopists choose to grade quality more generally as adequate vs. inadequate. To accommodate this variation, bowel preparation ratings have been dichotomized into adequate (excellent, good, fair, or adequate ratings) vs. inadequate (poor or inadequate ratings). Adequate is scored as 1 and indicates better quality of bowel preparation than inadequate which is score

GroupValue95% CI
Tailored DVD22
Tailored DVD + Patient Navigation39
Usual Care18
Colonoscopy-Related Procedural Anxiety for Participants Completing a Colonoscopy Secondary · 12 months post-baseline interview

Colonoscopy-related procedural anxiety is measured by self-report using the 6-item short form of the State Anxiety Scale of the State-Trait Anxiety Inventory. Each item is scored from 1 to 4 (1=not at all; 4=very much so) with higher scores indicating greater anxiety.

GroupValue95% CI
Tailored DVD2.46± 0.78
Tailored DVD + Patient Navigation2.23± 0.67
Usual Care2.28± 0.76
Satisfaction With Colonoscopy Experience Secondary · 12 months post-baseline interview

Satisfaction with the colonoscopy experience is measured by self-report using a single item developed by the research team. Satisfaction is rated from 1 to 4 where 1=not at all satisfied, 2=a little satisfied, 3=mostly satisfied, and 4=completely satisfied. Scores range from 1 to 4 with higher scores indicating greater satisfaction.

GroupValue95% CI
Tailored DVD3.38± 0.96
Tailored DVD + Patient Navigation3.60± 0.78
Usual Care3.13± 1.06
Participants Completing a Fecal Immunochemical Test (FIT) Per Electronic Medical Record Documentation Secondary · 12 months post-baseline interview

Number of participants completing a FIT is measured by electronic medical record review (EMR). Dates of FIT analysis are extracted from the EMR.

GroupValue95% CI
Tailored DVD15
Tailored DVD + Patient Navigation13
Usual Care8
Participants Who Self-Reported Completing CRC Screening Secondary · 6-9 months post-baseline interview

Number of participants who reported completing CRC screening by any test (defined as colonoscopy or FIT) during the 6 or 9 month post-baseline telephone interview.

GroupValue95% CI
Tailored DVD48
Tailored DVD + Patient Navigation59
Usual Care43
Participants Who Self-Reported Completing a Colonoscopy Secondary · 6-9 months post-baseline interview

Number of participants who reported completing a colonoscopy during the 6 or 9 month post-baseline telephone interview.

GroupValue95% CI
Tailored DVD26
Tailored DVD + Patient Navigation46
Usual Care27
Participants Who Self-Reported Completing a Fecal Immunochemical Test (FIT) Secondary · 6-9 months post-baseline interview

Number of participants who reported completing a FIT during the 6 or 9 month post-baseline telephone interview.

GroupValue95% CI
Tailored DVD34
Tailored DVD + Patient Navigation28
Usual Care20
Change in Knowledge of CRC and Screening Secondary · 6 months post-baseline interview

Change from baseline in knowledge of CRC and screening is measured at 6 months by self-report using a 9-item multidimensional scale. Each item is scored as 1=correct or 0=incorrect and summed to yield a scale score. Scores range from 0 to 9 with higher summated scores indicating greater knowledge of CRC and screening tests. The mean of the 9 items is calculated at baseline and 6 months post-baseline. Change from baseline equals the mean at 6 months minus the mean at baseline. Change can range from -9 to 9 with positive values indicating an increase in knowledge.

GroupValue95% CI
Tailored DVD1.14± 0.24
Tailored DVD + Patient Navigation1.32± 0.25
Usual Care0.75± 0.23
Change in Perceived Risk for CRC Secondary · 6 months post-baseline interview

Change from baseline in perceived risk for CRC is measured by self-report at 6 months using a 3-item scale. We ask participants how likely it is that they will get colon cancer sometime during their lifetime, within the next 10 years, and within the next 5 years. Each item is scored from 1 to 4 (1=very unlikely; 4=very likely). Higher scores indicate a higher perceived risk for getting CRC. The mean of the 3 items is calculated at baseline and 6 months. Change in perceived risk equals the mean at 6 months minus the mean at baseline. Change can range from -3 to 3 with positive values indicating

GroupValue95% CI
Tailored DVD0.23± 0.11
Tailored DVD + Patient Navigation0.03± 0.11
Usual Care0.18± 0.11

Sponsor's own description

The purpose of this study is to test different approaches to help people understand the purpose of colorectal cancer (CRC) screening, two screening test options available, and the barriers to screening so they can make informed decisions about CRC screening. Participants will be randomly assigned to one of three groups: (1) one group will receive a tailored digital video disc (DVD) in the mail; (2) another group will receive the mailed DVD plus telephone calls from a patient navigator; and (3) the third group will receive the care normally provided by the healthcare system's endoscopy department. The investigators hypothesize the following: (1) participants who receive the tailored DVD plus the patient navigation intervention will have higher rates of CRC screening with the fecal immunochemical test (FIT), colonoscopy, or either screening test compared to those who receive the tailored DVD alone; (2) participants who receive either intervention (DVD only or DVD plus patient navigation) will have higher rates of CRC screening with FIT, colonoscopy, or either screening test than those who receive usual care; and (3) participants who receive either intervention who complete colonoscopy will have better quality of bowel preparation, less anxiety about the procedure, and greater satisfaction with the colonoscopy experience than those who receive usual care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Patient Navigation Plus Tailored Digital Video Disc Increases Colorectal Cancer Screening Among Low-Income and Minority Patients Who Did Not Attend a Scheduled Screening Colonoscopy: A Randomized Trial.
    Rawl SM, Perkins SM, Tong Y, Katz ML, et al · · 2024 · cited 6× · PMID 38470961 · DOI 10.1093/abm/kaae013

Verify or expand the search:

Other recruiting trials for Colorectal Cancer

Currently open trials in the same condition.

Other Indiana University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03200366.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing